Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Contraceptive market, 2015 - 2021 (USD Billion)

2.2. Global Contraceptive market: Snapshot

Chapter 3. Contraceptive Market  Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global Contraceptive market drivers: Impact Analysis

3.2.2. Increasing prevalence of sexually transmitted infections

3.2.3. Increasing women population

3.3. Global Contraceptive market Restraints: Impact Analysis


3.3.1. Increasing prevalence of side effects due to improper use of contraception products

3.4. Opportunities


3.4.1. Untapped market like developing countries and increasing medical tourism

3.5. Porters Five Forces Analysis


3.5.1. Bargaining Power Of Suppliers

3.5.2. Bargaining Power Of Buyers

3.5.3. Threat From New Entrants

3.5.4. Threat From New Substitutes

3.5.5. Degree Of Competition

3.6. Market Attractiveness Analysis


3.6.1. Market Attractiveness Analysis, by method type segment

Chapter 4. Global Contraceptive Market  Competitive Landscape


4.1. Company Market Share, 2014 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Source Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Technology And Regional Expansion

4.3. Technology Portfolio

4.4. Patent Analysis (2011-2016)


4.4.1. Patent Trend

4.4.2. Patent Share By Company

4.4.3. By Region

Chapter 5. Global Contraceptive Market  Method type Analysis


5.1. Global Contraceptive market: Method type Segment Overview


5.1.1. Global Contraceptive market Revenue Share, By Method type Segment, 2015 And 2021

5.2. Contraceptive pills


5.2.1. Global Contraceptive market for contraceptive pills, 2015 - 2021 (USD Billion)

5.3. Injectables


5.3.1. Global Contraceptive market for Injectables, 2015 - 2021 (USD Billion)

5.4. Female sterilization


5.4.1. Global Contraceptive market for female sterilization, 2015 - 2021 (USD Billion)

5.5. Intrauterine devices  systems


5.5.1. Global Contraceptive market for intrauterine devices  systems, 2015 - 2021 (USD Billion)

5.6. Male condom


5.6.1. Global Contraceptive market for male condom, 2015 - 2021 (USD Billion)

5.7. Emergency contraception


5.7.1. Global Contraceptive market for Other, 2015 - 2021 (USD Billion)

5.8. Others


5.8.1. Global Contraceptive market for emergency contraception, 2015 - 2021 (USD Billion)

Chapter 6. Global Contraceptive market  Regional Segment Analysis


6.1. Global Contraceptive market: Regional Overview


6.1.1. Global Contraceptive market Revenue Share, By Region, 2014 And 2020

6.2. North America


6.2.1. North America Contraceptive market Revenue, by method type, 2015 - 2021 , (USD Billion)

6.3. Europe


6.3.1. Europe Contraceptive market Revenue, by method type, 2015 - 2021 , (USD Billion)

6.4. Asia Pacific


6.4.1. Asia Pacific Contraceptive market Revenue, by method type classification, 2015 - 2021 , (USD Billion)

6.5. Latin America


6.5.1. Latin America Contraceptive market Revenue, by method type, 2015 - 2021 , (USD Billion)

6.6. Middle East and Africa


6.6.1. Middle East and Africa Contraceptive market Revenue, by method type, 2015 - 2021 , (USD Billion)

Chapter 7. Company Profile


7.1. The Female Health Company


7.1.1. Overview

7.1.2. Financials

7.1.3. Technology Portfolio

7.1.4. Business Strategy

7.1.5. Recent Developments

7.2. Teva Pharmaceutical Industries


7.2.1. Overview

7.2.2. Financials

7.2.3. Technology Portfolio

7.2.4. Business Strategy

7.2.5. Recent Developments

7.3. Bayer Healthcare Pharmaceuticals


7.3.1. Overview

7.3.2. Financials

7.3.3. Technology Portfolio

7.3.4. Business Strategy

7.3.5. Recent Developments

7.4. Piramal Healthcare Limited


7.4.1. Overview

7.4.2. Financials

7.4.3. Technology Portfolio

7.4.4. Business Strategy

7.4.5. Recent Developments

7.5. Reckitt Benckiser Plc.


7.5.1. Financials

7.5.2. Technology Portfolio

7.5.3. Business Strategy

7.5.4. Recent Developments

7.6. Cipla Limited


7.6.1. Financials

7.6.2. Technology Portfolio

7.6.3. Business Strategy

7.6.4. Recent Developments

7.7. Novartis AG


7.7.1. Overview

7.7.2. Financials

7.7.3. Technology Portfolio

7.7.4. Business Strategy

7.7.5. Recent Developments

7.8. Lupin Pharmaceuticals, Inc,


7.8.1. Overview

7.8.2. Financials

7.8.3. Technology Portfolio

7.8.4. Business Strategy

7.8.5. Recent Developments

7.9. Pfizer, Inc.


7.9.1. Overview

7.9.2. Financials

7.9.3. Technology Portfolio

7.9.4. Business Strategy

7.9.5. Recent Developments

7.10. Amgen Inc.


7.10.1. Overview

7.10.2. Financials

7.10.3. Technology Portfolio

7.10.4. Business Strategy

7.10.5. Recent Developments

7.11. Sun Pharmaceutical Industries Ltd.


7.11.1. Overview

7.11.2. Financials

7.11.3. Technology Portfolio

7.11.4. Business Strategy

7.11.5. Recent Developments

7.12. Glenmark Pharmaceuticals


7.12.1. Overview

7.12.2. Financials

7.12.3. Technology Portfolio

7.12.4. Business Strategy

7.12.5. Recent Developments